antibody+

The Benchmark Company’s Senior Equity Analyst, Aydin Huseynov, M.D., CFA. on COVID-19 backup plan.

Antibody Therapies Take the Spotlight as Covid-19 ‘Plan B’

Click here for full Article

antibody+

November 1, 2024

Senior Analyst Mark Palmer Quoted in Bloomberg Article Regarding MicroStrategy’s (Nasdaq: MSTR) Stock Performance

November 1, 2024

Senior Analyst Matthew Harrigan Featured in Variety Article Discussing Lionsgate (NYSE: LGF.A)

October 8, 2024

John Borer Joins Lytham Partners’ Fall 2024 Investor Conference as Panelist

The Benchmark Company Announces “Healthcare House Call” Upcoming Virtual 1×1 Investor Conference

The Benchmark Company acted as financial advisor to Rainmaker Worldwide in Sphere 3D’s acquisition.